Search Results - "Franano, F Nicholas"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1
  2. 2

    The ability of serum from alpha 1-antitrypsin-deficient patients to inhibit PRT-201, a recombinant human type I pancreatic elastase by Qamar, Amir A., Burke, Steven K., Lafleur, Jason D., Ding, Bee C., Bland, Kimberly S., Wong, Marco D., Gustafson, Pamela N., Blair, Andrew T., Franano, F. Nicholas

    Published in Biotechnology and applied biochemistry (01-01-2012)
    “…PRT‐201 is a recombinant human pancreatic elastase under development as a treatment for blood vessels to promote hemodialysis access patency. Proteases such as…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Recombinant Human Elastase Alters the Compliance of Atherosclerotic Tibial Arteries After Ex Vivo Angioplasty by Burke, Steven K, Bingham, Karen, Moss, Emma, Gottlieb, Daniel P, Wong, Marco D, Bland, Kimberly S, Franano, F Nicholas

    Published in Journal of cardiovascular pharmacology (01-04-2016)
    “…PURPOSE:This study was designed to determine whether vonapanitase (formerly PRT-201), a recombinant human elastase, treatment can fragment the protein elastin…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Effects of Recombinant Human Type I Pancreatic Elastase on Human Atherosclerotic Arteries by Burke, Steven K, Macdonald, Karen, Moss, Emma, Bunton, David, Starcher, Barry, Wong, Marco D, Bland, Kimberly S, Franano, F Nicholas

    Published in Journal of cardiovascular pharmacology (01-12-2014)
    “…RATIONALE:At physiologic pressures, elastic fibers constrain artery diameter. Local treatment of atherosclerotic arteries with PRT-201, a recombinant type I…”
    Get full text
    Journal Article
  7. 7
  8. 8

    In Vitro Study of a Medical Device to Enhance Arteriovenous Fistula Eligibility and Maturation by Loree, Howard M, Agyapong, George, Favreau, Elyse G, Ngai, Gwendolyn A, Tansley, Geoff D, Dixon, Bradley S, Franano, F Nicholas

    Published in ASAIO journal (1992) (01-07-2015)
    “…The arteriovenous fistula eligibility (AFE) system (Flow Forward Medical, Olathe, KS) is a small, temporary, wearable rotary blood pump system designed to…”
    Get full text
    Journal Article
  9. 9

    Studies of human pancreatic elastase treatment of rabbit and human vein rings to predict human therapeutic doses by Burke, Steven K., Bunton, David, Bingham, Karen, Moss, Emma, Bland, Kimberly S., Starcher, Barry, Wong, Marco D., Franano, F. Nicholas

    Published in Pharmacology research & perspectives (01-06-2016)
    “…Vascular tissue contains abundant elastic fibers that contribute to vessel elasticity. Vonapanitase (formerly PRT‐201) is a recombinant human chymotrypsin‐like…”
    Get full text
    Journal Article
  10. 10

    Data-Based Modelling of the Arteriovenous Fistula Eligibility (AFE) System for Wall Shear Stress Estimation by Golesorkhie, Farya, Barnes, Zachary, Yang, Fuwen, Loree, Howard M., Franano, F. Nicholas, Vlacic, Ljubo, Tansley, Geoff

    “…The AFE System is a medical device intended to dilate the cephalic vein by increasing the blood flow and wall shear stress (WSS) in the vein over a period of…”
    Get full text
    Conference Proceeding
  11. 11
  12. 12
  13. 13

    Metabolism of receptor targeted 111In-DTPA-glycoproteins: identification of 111In-DTPA-epsilon-lysine as the primary metabolic and excretory product by Franano, F N, Edwards, W B, Welch, M J, Duncan, J R

    Published in Nuclear medicine and biology (01-11-1994)
    “…The hepatic and renal retention of indium-111 (111In) from 111In-labeled polypeptides has been the subject of many investigations. Because the lysosome is a…”
    Get more information
    Journal Article
  14. 14

    Biodistribution and metabolism of targeted and nontargeted protein-chelate-gadolinium complexes: Evidence for gadolinium dissociation in vitro and in vivo by Franano, F.Nicholas, Edwards, W.Barry, Welch, Michael J., Brechbiel, Martin W., Gansow, Otto A., Duncan, James R.

    Published in Magnetic resonance imaging (1995)
    “…The intracellular metabolism of receptor-targeted 153Gd-DTPA-glycoproteins was studied in vitro and in vivo. These agents bound to cell surface receptors,…”
    Get full text
    Journal Article